Literature DB >> 9449698

Local and systemic cytokine responses during experimental human influenza A virus infection. Relation to symptom formation and host defense.

F G Hayden1, R Fritz, M C Lobo, W Alvord, W Strober, S E Straus.   

Abstract

To further understand the role of cytokine responses in symptom formation and host defenses in influenza infection, we determined the levels of IL-1beta, IL-2, IL-6, IL-8, IFN-alpha, TGF-beta, and TNF-alpha in nasal lavage fluid, plasma, and serum obtained serially from 19 volunteers experimentally infected with influenza A/Texas/36/91 (H1N1) and correlated these levels with various measures of infection and illness severity. We found that IL-6 and IFN-alpha levels in nasal lavage fluids peaked early (day 2) and correlated directly with viral titers, temperature, mucus production, and symptom scores. IL-6 elevations were also found in the circulation at this time point. In contrast, TNF-alpha responses peaked later (day 3 in plasma, day 4 in nasal fluids), when viral shedding and symptoms were subsiding. Similarly, IL-8 peaked late in the illness course (days 4-6) and correlated only with lower respiratory symptoms, which also occurred late. None of IL-1beta, IL-2, or TGF-beta levels increased significantly. These data implicate IL-6 and IFN-alpha as key factors both in symptom formation and host defense in influenza.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9449698      PMCID: PMC508608          DOI: 10.1172/JCI1355

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  23 in total

Review 1.  Influenza virus infections and immunity: a review of human and animal models.

Authors:  K B Renegar
Journal:  Lab Anim Sci       Date:  1992-06

Review 2.  Interleukin-6: an overview.

Authors:  J Van Snick
Journal:  Annu Rev Immunol       Date:  1990       Impact factor: 28.527

3.  Estimation of nasal epithelial lining fluid using urea as a marker.

Authors:  H C Kaulbach; M V White; Y Igarashi; B K Hahn; M A Kaliner
Journal:  J Allergy Clin Immunol       Date:  1993-09       Impact factor: 10.793

4.  Phase I trial of subcutaneous interleukin-6 in patients with advanced malignancies.

Authors:  J Weber; J C Yang; S L Topalian; D R Parkinson; D S Schwartzentruber; S E Ettinghausen; H Gunn; A Mixon; H Kim; D Cole
Journal:  J Clin Oncol       Date:  1993-03       Impact factor: 44.544

5.  Stimulation of tumor necrosis factor secretion by purified influenza virus neuraminidase.

Authors:  M Houde; D J Arora
Journal:  Cell Immunol       Date:  1990-08       Impact factor: 4.868

6.  A kinetic study of immune mediators in the lungs of mice infected with influenza A virus.

Authors:  T Hennet; H J Ziltener; K Frei; E Peterhans
Journal:  J Immunol       Date:  1992-08-01       Impact factor: 5.422

7.  Presence of interferon in acute- and convalescent-phase sera of humans with influenza or influenza-like illness of undetermined etiology.

Authors:  J A Green; R P Charette; T J Yeh; C B Smith
Journal:  J Infect Dis       Date:  1982-06       Impact factor: 5.226

8.  Influenza A virus infection of macrophages. Enhanced tumor necrosis factor-alpha (TNF-alpha) gene expression and lipopolysaccharide-triggered TNF-alpha release.

Authors:  J H Gong; H Sprenger; F Hinder; A Bender; A Schmidt; S Horch; M Nain; D Gemsa
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

9.  Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells.

Authors:  A M Choi; D B Jacoby
Journal:  FEBS Lett       Date:  1992-09-14       Impact factor: 4.124

10.  Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation.

Authors:  Z Zhu; W Tang; A Ray; Y Wu; O Einarsson; M L Landry; J Gwaltney; J A Elias
Journal:  J Clin Invest       Date:  1996-01-15       Impact factor: 14.808

View more
  285 in total

Review 1.  Molecular pathways in virus-induced cytokine production.

Authors:  T H Mogensen; S R Paludan
Journal:  Microbiol Mol Biol Rev       Date:  2001-03       Impact factor: 11.056

2.  Breastfeeding is associated with the production of type I interferon in infants infected with influenza virus.

Authors:  Guillermina A Melendi; Silvina Coviello; Niranjan Bhat; Johanna Zea-Hernandez; Fausto M Ferolla; Fernando P Polack
Journal:  Acta Paediatr       Date:  2010-10       Impact factor: 2.299

3.  Factors that make an infectious disease outbreak controllable.

Authors:  Christophe Fraser; Steven Riley; Roy M Anderson; Neil M Ferguson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-04-07       Impact factor: 11.205

4.  Chinese guidelines for diagnosis and treatment of influenza (2011).

Authors:  Nan-Shan Zhong; Yi-Min Li; Zi-Feng Yang; Chen Wang; You-Ning Liu; Xing-Wang Li; Yue-Long Shu; Guang-Fa Wang; Zhan-Cheng Gao; Guo-Hua Deng; Li-Xian He; Xiu-Ming Xi; Bin Cao; Kun-Ling Shen; Hao Wu; Ping-An Zhou; Qing-Quan Li
Journal:  J Thorac Dis       Date:  2011-12       Impact factor: 2.895

5.  Economic analysis of the use of facemasks during pandemic (H1N1) 2009.

Authors:  Samantha M Tracht; Sara Y Del Valle; Brian K Edwards
Journal:  J Theor Biol       Date:  2012-01-28       Impact factor: 2.691

6.  Respiratory virus transmission dynamics determine timing of asthma exacerbation peaks: Evidence from a population-level model.

Authors:  Rosalind M Eggo; James G Scott; Alison P Galvani; Lauren Ancel Meyers
Journal:  Proc Natl Acad Sci U S A       Date:  2016-02-08       Impact factor: 11.205

Review 7.  Pathology of human influenza revisited.

Authors:  Thijs Kuiken; Jeffery K Taubenberger
Journal:  Vaccine       Date:  2008-09-12       Impact factor: 3.641

8.  Increased interleukin-6 levels in nasal lavage samples following experimental influenza A virus infection.

Authors:  D Gentile; W Doyle; T Whiteside; P Fireman; F G Hayden; D Skoner
Journal:  Clin Diagn Lab Immunol       Date:  1998-09

9.  Bacterial lysates improve the protective antibody response against respiratory viruses through Toll-like receptor 4.

Authors:  Silvina Coviello; Vera Wimmenauer; Fernando P Polack; Pablo M Irusta
Journal:  Hum Vaccin Immunother       Date:  2014-11-19       Impact factor: 3.452

10.  Effectiveness and cost-effectiveness of vaccination against pandemic influenza (H1N1) 2009.

Authors:  Nayer Khazeni; David W Hutton; Alan M Garber; Nathaniel Hupert; Douglas K Owens
Journal:  Ann Intern Med       Date:  2009-12-15       Impact factor: 25.391

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.